You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
|
|---|---|
| Published in |
The Lancet, January 2013
|
| DOI | 10.1016/s0140-6736(12)61811-x |
| Pubmed ID | |
| Authors |
Josef S Smolen, Peter Nash, Patrick Durez, Stephen Hall, Elena Ilivanova, Fedra Irazoque-Palazuelos, Pedro Miranda, Min-Chan Park, Karel Pavelka, Ronald Pedersen, Annette Szumski, Constance Hammond, Andrew S Koenig, Bonnie Vlahos |
| Abstract |
Clinical remission and low disease activity are essential treatment targets in patients with rheumatoid arthritis. Although moderately active rheumatoid arthritis is common, treatment effects in moderate disease have not been well studied. Additionally, optimum use of biologics needs further investigation, including the use of induction, maintenance, and withdrawal treatment strategies. The aim of the PRESERVE trial was to assess whether low disease activity would be sustained with reduced doses or withdrawal of etanercept in patients with moderately active disease. |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 13% |
| France | 2 | 9% |
| Japan | 1 | 4% |
| Ecuador | 1 | 4% |
| Argentina | 1 | 4% |
| United Kingdom | 1 | 4% |
| Spain | 1 | 4% |
| Venezuela, Bolivarian Republic of | 1 | 4% |
| Australia | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 11 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 78% |
| Practitioners (doctors, other healthcare professionals) | 4 | 17% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 234 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Switzerland | 1 | <1% |
| Netherlands | 1 | <1% |
| Paraguay | 1 | <1% |
| Canada | 1 | <1% |
| Singapore | 1 | <1% |
| Argentina | 1 | <1% |
| Japan | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 224 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 40 | 17% |
| Other | 25 | 11% |
| Student > Bachelor | 23 | 10% |
| Student > Ph. D. Student | 22 | 9% |
| Student > Postgraduate | 18 | 8% |
| Other | 60 | 26% |
| Unknown | 46 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 129 | 55% |
| Biochemistry, Genetics and Molecular Biology | 11 | 5% |
| Agricultural and Biological Sciences | 9 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Nursing and Health Professions | 7 | 3% |
| Other | 16 | 7% |
| Unknown | 53 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2022.
All research outputs
#1,595,004
of 26,017,215 outputs
Outputs from The Lancet
#10,836
of 43,155 outputs
Outputs of similar age
#14,309
of 299,183 outputs
Outputs of similar age from The Lancet
#113
of 429 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 299,183 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 429 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.